A study suggests that a new compound, one on the threshold of final testing in humans, may be more potent and safer for treating “bird flu” than the antiviral drug best known by the trade name Tamiflu.
A study suggests that a new compound, one on the threshold of final testing in humans, may be more potent and safer for treating “bird flu” than the antiviral drug best known by the trade name Tamiflu.
Leave a Reply
You must be logged in to post a comment.